Pipeline

Products in development

Pre-clinical

Phase 1

Phase 2

Phase 3

Market approval

Anotop: Topical Diltiazem

Chronic anal fissure pain

Phase 3: Complete

Pre-clinical

Phase 1

Phase 2

Phase 3

Market approval

ALFA: Eicosapentaenoic Acid (EPA)

Familial Adenomatous Polyposis (FAP)

Phase 3: In progress

Ulcerative Colitis (UC)

Phase 2: In progress

Pre-clinical

Phase 1

Phase 2

Phase 3

Market approval

Ortem: Topical Metronidazole

Pilonidal Sinus Disease (PSD)

Phase 2: In progress

Perianal Crohn’s Disease

Phase 2: In progress

Anotop: Topical Diltiazem

Phase 3

Chronic anal fissure pain

Phase 3: Complete

ALFA: Eicosapentaenoic Acid (EPA)

Phase 2

Familial Adenomatous Polyposis (FAP)

Complete

Ulcerative Colitis (UC)

In progress

Phase 3

Familial Adenomatous Polyposis (FAP)

In progress

Ulcerative Colitis (UC)

Not started

Ortem: Topical Metronidazole

Phase 2

Pilonidal Sinus Disease (PSD)

In progress

Phase 2

Perianal Crohn’s Disease

In progress